Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bazedoxifene + conjugated estrogen for perimenopausal depression
ACTRN12620001015932Phase 2Recruiting
- Sponsor
- Monash University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bazedoxifene and conjugated estrogens in major depressive disorder (MDD) and menopause (4 arms), sponsored by Monash University. Primary endpoint: Montgomery-Asberg Depression Rating Scale. Started Dec 2020; status: recruiting.
02
Drugs
bazedoxifeneconjugated estrogens
03
Conditions
major depressive disorder (MDD)menopause
Beyond the preview
Go deeper on ACTRN12620001015932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001015932.